Anxiety - Articles - Page 3 | CARLAT PUBLISHING

Ask the Editor: Is Silexan Safe for Children and Adolescents?

October 1, 2022

I’ve heard that Silexan/CalmAid lavender oil has been recommended for adults as a natural anxiolytic. Is it safe for kids?

Can CBD Work for PTSD?

September 25, 2022

Sin Yan Lo, PMHNP-BC

Sin Yan Lo, PMHNP-BC. Ms. Lo, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Cannabidiol (CBD oil) is a popular self-remedy for anxiety and insomnia. A new study tests the drug in PTSD.

SAINT TMS Cleared for Treatment-Resistant Depression

September 12, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

On 9/6/22 the FDA approved Stanford’s SAINT Neuromodulation, an accelerated version of TMS that has raised hopes with unusually high remission rates.

Benzodiazepines: A Reevaluation of Their Benefits and Dangers

August 23, 2022

Carl Salzman MD

Carl Salzman, MD

Professor of Psychiatry at Harvard Medical School and past chairman of the American Psychiatric Association Benzodiazepine Task Force. Interview by Marcia L. Zuckerman, MD. Board member of The Carlat Psychiatry Report; outpatient psychiatrist, Hallmark Health, Medford, MA; clinical assistant professor in psychiatry, Tufts School of Medicine. Edited by Chris Aiken, MD. Editor-in-Chief of TCPR; practicing psychiatrist, Winston-Salem, NC.

Drs. Salzman, Zuckerman, and Aiken have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Former Chairman of the American Psychiatric Association Benzodiazepine Task Force Carl Salzman explains the legitimate medical use of benzodiazepines and their relevance in psychiatric practice.

What Works for Treatment Resistant Anxiety?

August 22, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Silexan, an extract from Lavender with pharmaceutical properties, is one of only two treatments with a large effect size in generalized anxiety disorder. We rank all the treatments by strength and look to see if any of them can work when the SSRIs do not.

What Gets in the Way of Antidepressants?

August 1, 2022

Chris Aiken, MD and Garrett Rossi, MD.

Garrett Rossi, MD.
Inpatient/consult attending psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.

Chris Aiken, MD.
Editor-in-Chief, The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC.

Dr. Rossi and Dr. Aiken, authors for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

Recent research has added to our understanding of factors that inhibit response to treatment, including major stress, nonadherence, and anxiety.

How Effective is Atomoxetine in Children and Adolescents

June 27, 2022

Joshua Feder, MD and Mara Goverman

With the recent approval of another non-stimulant ADHD medication (viloxazine, brand name Qelbree), this is a good time to revisit atomoxetine.

12 New Findings on Quetiapine

June 6, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

12 clinically relevant findings from the past 3 years on quetiapine (Seroquel), including new side effects, dosing strategies, withdrawal phenomena, and new uses in bipolar with OCD.

Uncommon Tips: Which Is Better—Citalopram or Escitalopram?

June 1, 2022

Chris Aiken, MD.

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Dr. Aiken has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Citalopram and escitalopram are very similar drugs, but there are reasons to prefer one over the other.

Quetiapine Reconsidered

June 1, 2022

Paul Riordan, MD.

Paul Riordan, MD. Assistant Consulting Professor of Psychiatry, Duke University. Dr. Riordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

It is the best of drugs; it is the worst of drugs. Quetiapine (Seroquel) has a few benefits that are unmatched by other medications, and here we explore where it fits in depression, bipolar, schizophrenia, as well as off-label uses like anxiety and sleep.